Juvenile Arthritis News

Increased levels of interleukin-37 are positively correlated with disease activity in adult-onset Still’s disease, according to findings published in Arthritis Research and Therapy.

A European group of experts has released a series of 22 recommendations for the diagnosis, measurement, treatment and future clinical trials of uveitis associated with juvenile idiopathic arthritis.

Following the implementation of standardized protocols for intravenous therapy use at a pediatric rheumatology infusion center, only 1.9% of all infusions were associated with adverse events, according to findings published in Pediatric Rheumatology.

Samsung Bioepis and Abbvie have reached a global settlement agreement regarding the commercialization of SB5, the proposed adalimumab biosimilar for Humira, according to a press release.

Patients with arthritis who are younger, have rheumatoid factor positivity and demonstrate higher disease activity at baseline are at an increased risk for experiencing methotrexate failure due to inefficacy, according to findings published in Arthritis Care & Research.

Subcutaneous abatacept used to treat polyarticular-course juvenile idiopathic arthritis improved symptoms, reached target therapeutic exposures across age and weight groups and was well tolerated over a 24-month period, according to findings published in Arthritis and Rheumatology.

The use of biologic medications for autoimmune diseases prior to or during pregnancy is not associated with an increased risk for preterm delivery or infants that are small for gestational age, according to findings published in the Annals of the Rheumatic Diseases.

Patients with early inflammatory polyarthritis diagnosed within the new millennium experienced improved disease activity, compared with those diagnosed during the early 1990s, according to findings published in the Annals of the Rheumatic Diseases.

Nearly two-thirds of patients and caregivers identified at least one adherence barrier to treatment for juvenile idiopathic arthritis, according to survey data published in the Journal of Rheumatology.

Few patients with inflammatory arthritis reported participating in a structured self-management care program, although many physicians reported providing self-management support within routine care, according to findings published in Arthritis Care and Research.